Differential Evolution Algorithm (DE) To Estimate The Coefficients Of Uniformity Of Water Distribution In Sprinkler Irrigation

Iran, has caused most of the water used and as much as possible to avoid losses. One of the important parameters in agriculture is water distribution uniformity coefficient (CU) in sprinkler irrigation. CU amount of water sprinkler operating depends on different pressure heads (P), riser height (RH), distance between sprinklers on lateral pipes (Sl) and the distance between lateral pipes (Sm). The best combination of the above parameters for maximum CU, is still unknown for applicators. In this research, CU quantities of zb model sprinkler (made in Iran) were measured at Hashemabad cotton research station of Gorgan under 3 different pressure heads (2.5, 3 and 3.5 atm), 2 riser heads (60 and 100 cm) and 7 sprinkler (Sl×Sm including 9×12, 9×15, 12×12, 15×12, 12×18, 15×15, 15×18m) arrangements. By using differential evolution algorithm (DE), CU equation was optimized and the best optimized coefficients obtained. In this algorithm, the coefficients F and CR equal to 2 and 0.5, respectively, with a population of 100 members and 1000 number of generations (iterations), provides the best results. Absolute error between the results of this algorithm with the measured results is 2.2%. As well as values Wilmot (d) and the root-mean square error (RMSE), equal to 0.919 and 2.126, respectively. This results show that this algorithm has high accuracy to estimate water distribution uniformity

Numerical Modeling Of Flow In The Vertical Drop With Inverse Apron

Drops are hydraulic structures that are commonly used in irrigation and waste water collection networks. A vertical drop balances the elevation difference between the channel slope and ground slope. Earlier investigations on this structure have mainly focused on experimental studies of the hydraulic characteristics. In this paper, the hydraulic characteristics of vertical drops with inverse apron have been studied numerically with used of Fluent software to solve the finite volume method. The volume of fluid (volume of fluid) was used for modeling the free surface. Flow characteristics such as downstream depth, pool depth and energy loss were calculated and compared with the experimental values. Different turbulent models and grids have been studied. The numerical results with a 52745-node grid, 1.5 meter downstream channel length, standard k-ε turbulence model and standard wall function showed the best agreement and the numerical downstream depth, pool depth and energy loss followed the theoretical equations very well. Finally the numerical impact velocities were compared to empirical equation for different cases and showed little discrepancy, therefore velocity characteristics of falling jet were calculated

Study of Hydraulic Properties and Design Criteria for a River Subsurface Intake without Cut Off

Experimental Studie

The synergistic effect of operational research and big data analytics in greening container terminal operations: A review and future directions

Container Terminals (CTs) are continuously presented with highly interrelated, complex, and uncertain planning tasks. The ever-increasing intensity of operations at CTs in recent years has also resulted in increasing environmental concerns, and they are experiencing an unprecedented pressure to lower their emissions. Operational Research (OR), as a key player in the optimisation of the complex decision problems that arise from the quay and land side operations at CTs, has been therefore presented with new challenges and opportunities to incorporate environmental considerations into decision making and better utilise the ‘big data’ that is continuously generated from the never-stopping operations at CTs. The state-of-the-art literature on OR's incorporation of environmental considerations and its interplay with Big Data Analytics (BDA) is, however, still very much underdeveloped, fragmented, and divergent, and a guiding framework is completely missing. This paper presents a review of the most relevant developments in the field and sheds light on promising research opportunities for the better exploitation of the synergistic effect of the two disciplines in addressing CT operational problems, while incorporating uncertainty and environmental concerns efficiently. The paper finds that while OR has thus far contributed to improving the environmental performance of CTs (rather implicitly), this can be much further stepped up with more explicit incorporation of environmental considerations and better exploitation of BDA predictive modelling capabilities. New interdisciplinary research at the intersection of conventional CT optimisation problems, energy management and sizing, and net-zero technology and energy vectors adoption is also presented as a prominent line of future research

Credit Card Fraud Detection Using Asexual Reproduction Optimization

As the number of credit card users has increased, detecting fraud in this domain has become a vital issue. Previous literature has applied various supervised and unsupervised machine learning methods to find an effective fraud detection system. However, some of these methods require an enormous amount of time to achieve reasonable accuracy. In this paper, an Asexual Reproduction Optimization (ARO) approach was employed, which is a supervised method to detect credit card fraud. ARO refers to a kind of production in which one parent produces some offspring. By applying this method and sampling just from the majority class, the effectiveness of the classification is increased. A comparison to Artificial Immune Systems (AIS), which is one of the best methods implemented on current datasets, has shown that the proposed method is able to remarkably reduce the required training time and at the same time increase the recall that is important in fraud detection problems. The obtained results show that ARO achieves the best cost in a short time, and consequently, it can be considered a real-time fraud detection system

Modelling continuous pharmaceutical and bio-based processes at plant-wide level: A roadmap towards efficient decision-making

The importance of developing simulation models for decision-making in pharmaceutical and bio-based production processes is elaborated in this article. The advantages of modelling continuous processes are outlined and certain barriers in this regard are identified. Although there have been some advancements in the field, there needs to be a larger international collaboration in this regard for providing reliable data for model validation, for development of generic model-based frameworks and implementing them in computer-aided platforms in the form of software tools

A risk assessment approach to improve the resilience of a seaport system using Bayesian networks

Over the years, many efforts have been focused on developing methods to design seaport systems, yet disruption still occur because of various human, technical and random natural events. Much of the available data to design these systems are highly uncertain and difficult to obtain due to the number of events with vague and imprecise parameters that need to be modelled. A systematic approach that handles both quantitative and qualitative data, as well as means of updating existing information when new knowledge becomes available is required. Resilience, which is the ability of complex systems to recover quickly after severe disruptions, has been recognised as an important characteristic of maritime operations. This paper presents a modelling approach that employs Bayesian belief networks to model various influencing variables in a seaport system. The use of Bayesian belief networks allows the influencing variables to be represented in a hierarchical structure for collaborative design and modelling of the system. Fuzzy Analytical Hierarchy Process (FAHP) is utilised to evaluate the relative influence of each influencing variable. It is envisaged that the proposed methodology could provide safety analysts with a flexible tool to implement strategies that would contribute to the resilience of maritime systems

Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

Background The COVID-19 pandemic highlighted gaps in health surveillance systems, disease prevention, and treatment globally. Among the many factors that might have led to these gaps is the issue of the financing of national health systems, especially in low-income and middle-income countries (LMICs), as well as a robust global system for pandemic preparedness. We aimed to provide a comparative assessment of global health spending at the onset of the pandemic; characterise the amount of development assistance for pandemic preparedness and response disbursed in the first 2 years of the COVID-19 pandemic; and examine expectations for future health spending and put into context the expected need for investment in pandemic preparedness. Methods In this analysis of global health spending between 1990 and 2021, and prediction from 2021 to 2026, we estimated four sources of health spending: development assistance for health (DAH), government spending, out-of-pocket spending, and prepaid private spending across 204 countries and territories. We used the Organisation for Economic Co-operation and Development (OECD)'s Creditor Reporting System (CRS) and the WHO Global Health Expenditure Database (GHED) to estimate spending. We estimated development assistance for general health, COVID-19 response, and pandemic preparedness and response using a keyword search. Health spending estimates were combined with estimates of resources needed for pandemic prevention and preparedness to analyse future health spending patterns, relative to need. Findings In 2019, at the onset of the COVID-19 pandemic, US$9·2 trillion (95$7·3 trillion (95% UI 7·2–7·4) in 2019; 293·7 times the $24·8 billion (95$43·1 billion in development assistance was provided to maintain or improve health. The pandemic led to an unprecedented increase in development assistance targeted towards health; in 2020 and 2021, $1·8 billion in DAH contributions was provided towards pandemic preparedness in LMICs, and$37·8 billion was provided for the health-related COVID-19 response. Although the support for pandemic preparedness is 12·2% of the recommended target by the High-Level Independent Panel (HLIP), the support provided for the health-related COVID-19 response is 252·2% of the recommended target. Additionally, projected spending estimates suggest that between 2022 and 2026, governments in 17 (95% UI 11–21) of the 137 LMICs will observe an increase in national government health spending equivalent to an addition of 1% of GDP, as recommended by the HLIP. Interpretation There was an unprecedented scale-up in DAH in 2020 and 2021. We have a unique opportunity at this time to sustain funding for crucial global health functions, including pandemic preparedness. However, historical patterns of underfunding of pandemic preparedness suggest that deliberate effort must be made to ensure funding is maintained

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed